MedTrace Logo

Creation of a Prospective Cohort of Healthy and Sick Subjects and of a Collection of Associated Biological Resources, for the Study of the Immune System and of Its Genetic and Environmental Determinants.

NCT03925272 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2200

Last updated 2022-05-17

No results posted yet for this study

Summary

CoSImmGEn is a protocol set up to respond to the current lack of healthy and sick population cohorts. Biological resources from these cohorts allow researchers to study the immune system and its genetic and environmental determinants. Those cohorts and collections are open not only to the Pasteurian community but also to the worldwide scientific community (both public and private) working in the field.

Conditions

  • Immune System and Related Disorders

Interventions

PROCEDURE

Collection of samples (blood, stool, etc.)

GENETIC

Genetic determinants analysis

PROCEDURE

Sample obtained after surgery performed in the context of care

Sponsors & Collaborators

  • Institut Pasteur

    lead INDUSTRY

Principal Investigators

  • Marie-Noelle Ungeheuer, PhD · Institut Pasteur - ICAReB

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-02-02
Primary Completion
2023-12-02
Completion
2023-12-02

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03925272 on ClinicalTrials.gov